176 related articles for article (PubMed ID: 19249404)
1. Role of aldosterone receptor antagonist eplerenone in aortic stenosis.
Ramaraj R
Am Heart J; 2009 Mar; 157(3):e13; author reply e17. PubMed ID: 19249404
[No Abstract] [Full Text] [Related]
2. Eplerenone treatment of aortic stenosis. [letter].
Marciniak TA
Am Heart J; 2009 Mar; 157(3):e15; author reply e17. PubMed ID: 19249405
[No Abstract] [Full Text] [Related]
3. A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
Stewart RA; Kerr AJ; Cowan BR; Young AA; Occleshaw C; Richards AM; Edwards C; Whalley GA; Freidlander D; Williams M; Doughty RN; Zeng I; White HD;
Am Heart J; 2008 Aug; 156(2):348-55. PubMed ID: 18657667
[TBL] [Abstract][Full Text] [Related]
4. Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction?
Doggrell S
Expert Opin Pharmacother; 2003 Sep; 4(9):1605-7. PubMed ID: 12943490
[No Abstract] [Full Text] [Related]
5. Evolving strategies for the use of spironolactone in cardiovascular disease.
Jolobe OM
Eur J Intern Med; 2013 Jun; 24(4):303-9. PubMed ID: 23245930
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone antagonism and myocardial infarction: from animals to man and back.
Solomon SD; Pfeffer MA
J Am Coll Cardiol; 2003 Nov; 42(9):1674-6. PubMed ID: 14607458
[No Abstract] [Full Text] [Related]
7. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?
Pitt B
J Card Fail; 2002 Dec; 8(6 Suppl):S491-3. PubMed ID: 12555163
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone antagonism and congestive heart failure: a new look at an old therapy.
Thohan V; Torre-Amione G; Koerner MM
Curr Opin Cardiol; 2004 Jul; 19(4):301-8. PubMed ID: 15218387
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
[TBL] [Abstract][Full Text] [Related]
10. New therapy update. Inspra (eplerenone tablets).
Kloner RA
Congest Heart Fail; 2003; 9(6):341-2. PubMed ID: 14688507
[No Abstract] [Full Text] [Related]
11. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
Tatsumi T; Matsubara H
Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
[No Abstract] [Full Text] [Related]
12. Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HF.
Jacob MS; Tang WH
Curr Heart Fail Rep; 2011 Mar; 8(1):7-13. PubMed ID: 21207206
[TBL] [Abstract][Full Text] [Related]
13. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats.
Burla AK; Neves MF; Oigman W; Mandarim-de-Lacerda CA
Int J Cardiol; 2007 Jan; 114(1):64-70. PubMed ID: 16650491
[TBL] [Abstract][Full Text] [Related]
15. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats.
Urabe A; Izumi T; Abe Y; Taniguchi I; Mochizuki S
Hypertens Res; 2006 Aug; 29(8):627-34. PubMed ID: 17137219
[TBL] [Abstract][Full Text] [Related]
16. [Aldosterone receptor antagonists in heart failure. Rightly brought back from retirement].
Kolloch R; Offers E
MMW Fortschr Med; 2003 Nov; 145(47):42-4, 47. PubMed ID: 14725033
[TBL] [Abstract][Full Text] [Related]
17. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction.
Masson S; Staszewsky L; Annoni G; Carlo E; Arosio B; Bai A; Calabresi C; Martinoli E; Salio M; Fiordaliso F; Scanziani E; Rudolph AE; Latini R
J Card Fail; 2004 Oct; 10(5):433-41. PubMed ID: 15470655
[TBL] [Abstract][Full Text] [Related]
18. Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms.
Vizzardi E; Sciatti E; Bonadei I; D'Aloia A; Tartière-Kesri L; Tartière JM; Cohen-Solal A; Metra M
Clin Res Cardiol; 2015 Dec; 104(12):1078-87. PubMed ID: 26058790
[TBL] [Abstract][Full Text] [Related]
19. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
[TBL] [Abstract][Full Text] [Related]
20. Eplerenone: cardiovascular protection.
Brown NJ
Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
